[HTML][HTML] Role of CD93 in Health and Disease
CD93 (also known as complement protein 1 q subcomponent receptor C1qR1 or C1qRp), is
a transmembrane glycoprotein encoded by a gene located on 20p11. 21 and composed of …
a transmembrane glycoprotein encoded by a gene located on 20p11. 21 and composed of …
Artificial intelligence-based preventive, personalized and precision medicine for cardiovascular disease/stroke risk assessment in rheumatoid arthritis patients: a …
M Al-Maini, M Maindarkar, GD Kitas… - Rheumatology …, 2023 - Springer
The challenges associated with diagnosing and treating cardiovascular disease
(CVD)/Stroke in Rheumatoid arthritis (RA) arise from the delayed onset of symptoms …
(CVD)/Stroke in Rheumatoid arthritis (RA) arise from the delayed onset of symptoms …
[HTML][HTML] Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
Y Cai, Q Yang, Y Yu, F Yang, R Bai… - Frontiers in pharmacology, 2023 - frontiersin.org
Lipid-lowering therapy is an important tool for the treatment of lipid metabolic diseases,
which are increasing in prevalence. However, the failure of conventional lipid-lowering …
which are increasing in prevalence. However, the failure of conventional lipid-lowering …
Changes in biomarkers of endothelial function, oxidative stress, inflammation and lipids after smoking cessation: A cohort study
ML Colsoul, N Goderniaux, S Onorati… - European journal of …, 2023 - Wiley Online Library
Background Tobacco use is known to be involved in the development of cardiovascular
diseases, which leads to premature mortality. Endothelial dysfunction, the first step in this …
diseases, which leads to premature mortality. Endothelial dysfunction, the first step in this …
[HTML][HTML] Diagnostic and prognostic role of CD93 in cardiovascular disease: a systematic review
Introduction. Cluster of Differentiation (CD) 93 (also known as complement protein 1 q
subcomponent receptor C1qR1 or C1qRp) is a transmembrane glycoprotein that can also …
subcomponent receptor C1qR1 or C1qRp) is a transmembrane glycoprotein that can also …
Hyperuricemia: A key contributor to endothelial dysfunction in cardiovascular diseases
X Wei, M Zhang, S Huang, X Lan, J Zheng… - The FASEB …, 2023 - Wiley Online Library
As an end product of purine metabolism, uric acid (UA) is a major endogenous antioxidant in
humans. However, impaired UA synthesis and excretion can lead to hyperuricemia (HUA) …
humans. However, impaired UA synthesis and excretion can lead to hyperuricemia (HUA) …
[HTML][HTML] Canagliflozin delays aging of HUVECs Induced by Palmitic Acid via the ROS/p38/JNK pathway
W Hao, W Shan, F Wan, J Luo, Y Niu, J Zhou, Y Zhang… - Antioxidants, 2023 - mdpi.com
Vascular aging is an important factor contributing to cardiovascular diseases, such as
hypertension and atherosclerosis. Hyperlipidemia or fatty accumulation may play an …
hypertension and atherosclerosis. Hyperlipidemia or fatty accumulation may play an …
[HTML][HTML] Targeting Endothelial HIF2α/ARNT Expression for Ischemic Heart Disease Therapy
K Ullah, L Ai, Z Humayun, R Wu - Biology, 2023 - mdpi.com
Simple Summary In this review paper, we discuss potential new therapies for ischemic heart
disease (IHD), a leading cause of death and disability around the world. IHD results from a …
disease (IHD), a leading cause of death and disability around the world. IHD results from a …
Nutraceutical potential of olive pomace: insights from cell‐based and clinical studies
CSA Monteiro, IA Adedara, EO Farombi… - Journal of the …, 2024 - Wiley Online Library
Olive oil production yields a substantial volume of by‐products, constituting up to 80% of the
processed fruits. The olive pomace by‐product represents a residue of significant interest …
processed fruits. The olive pomace by‐product represents a residue of significant interest …
[HTML][HTML] Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies
D Das, NR Shruthi, A Banerjee, G Jothimani… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Metabolic syndrome (MetS) is a multifaceted condition that increases the possibility of
developing atherosclerotic cardiovascular disease. MetS includes obesity, hypertension …
developing atherosclerotic cardiovascular disease. MetS includes obesity, hypertension …